Sex hormones and systemic lupus erythematosus

Rheumatic Disease Clinics of North America

Volumn 26, Issue 4, 2000, Pages 951-968

  Lahita, Robert G ^b  

^a ST VINCENT S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN; FOLLITROPIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PHOSPHOLIPID ANTIBODY; PRASTERONE; PROGESTERONE; PROLACTIN; SEX HORMONE; T LYMPHOCYTE RECEPTOR; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HORMONE SUBSTITUTION; HUMAN; KLINEFELTER SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

EID: 0033769037     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70178-2     Document Type: Article

References (118)

1. Antiandrogenic suppression of lymphocytic blastogenes: In vitro and in vivo observations
2. Effects of short term administration of sex hormones on normal and autoimmune mice
3. Aortic defects in systemic lupus erythematosus
4. Sexual dimorphism in rheumatic diseases
5. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action
6. Prognostic factors in lupus nephritis. Contribution of renal histologic data
7. Occult systemic lupus erythematosus in elderly men
8. Age and sex associations of 40 autoimmune diseases
9. Origin of the inbred New Zealand mouse strains
10. In vitro lymphocyte responses to PHA show co-variation with the menstrual cycle
11. Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice
12. Progressive polyarthritis and Klinefelter's syndrome
13. Specific estradiol binding in cytosols from the thymus glands of normal and hormone-treated male rats
14. Formation of co-valent adducts between cortisol and 16-alpha-hydroxyestrone and protein, possible role in pathogenesis of cortisol toxicity and SLE
15. The reaction of 16-α hydroxyestrone with erythrocytes in vitro and in vivo
16. Anti-estrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus
17. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus
18. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits
19. Fatal exacerbation of systemic lupus erythematosus after induction of ovulation
20. Oral contraceptives and exacerbations of SLE
21. Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8 positive cells
22. Specific estrogen binding sites in human lymphoid cells and thymic cells
23. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations
24. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus
25. Androgen dependent sexual dimorphism of the immune system
26. Effect of castration on male determined acceleration of autoimmune disease in BXSB mice
27. Male determined accelerated autoimmune disease in BXSB mice: Transfer by bone marrow and spleen cells
28. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures
29. SLE and Klinefelter's syndrome
30. Biological properties of 16-alpha hydroxyestrone: Implications in estrogen physiology and pathophysiology
31. The role of estrogen androgen imbalance in rheumatic diseases
32. Systemic lupus erythematosus and Klinefelter's syndrome
33. Sex and stress steroids interactions and the immune system: Evidence for a neuroendocrine-immunological sexual dimorphism
34. The influence of the gonads and the adrenal glands on the immune response to skin grafts
35. The importance of hormones in the regulation of the immune system
36. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis
37. Regulation of the immune system by sex steroids
38. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
39. Congenital hypothyroidism and Klinefelter's syndrome
40. Testosterone inhibits and induces apoptosis in rat seminiferous tubules in a stage-specific manner: In situ quantification in squash preparations after administration of ethane dimethane sulfonate
41. The B-cell development independent of bursa of Fabricius but dependent upon the thymus in chickens treated with testosterone propionate
42. The development of unusual B-cell functions in the testosterone-propionate treated chicken
43. Humoral immune responses characteristics of testosterone propionate treated chickens
44. Autoimmune diseases in mice
45. The immunology and pathology of NZB mice
46. Current understanding of systemic lupus erythematosus
47. Concentration of 16 alpha hydroxyestrone in human plasma as measured by a specific RIA
48. Immunologic sex differences and the female preponderance in systemic lupus erythematosus
49. Systemic lupus erythematosus in men: Genetic and endocrine features
50. Prolactin, immunoregulation, and autoimmune diseases
51. Inhibitory effects of estrogen, progesterone, androgen and glucocorticoid on death of neonatal mouse uterine epithelial cells induced to proliferate by estrogen
52. Low plasma androgens in women with active or quiescent SLE
53. Les androgenes plasmatiques chez les femmes atteintes de lupus erythemateux dissemine (LED)
54. Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus
55. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
56. Hormonal regulation of the expression of Ia antigens on mammary gland epithelia
57. A case report of Klinefelter's syndrome associated with progressive systemic sclerosis
58. Klinefelter's syndrome associated with progressive systemic sclerosis: Report of a case and review of the literature
59. Dehydroepiandrosterone (DHEA) and lupus erythematosus: An update
60. Gender and age in lupus
61. The importance of estrogens in systemic lupus erythematosus
62. The influence of sex hormones on the disease systemic lupus erythematosus
63. Sex steroids and the rheumatic diseases
64. Sex steroids and SLE: Metabolism of androgens to estrogens
65. Sex hormones as immunomodulators of disease
66. Klinefelter's syndrome: Hormone metabolism in hypogonadal males with systemic lupus erythematosus
67. Familial systemic lupus erythematosus in males
68. Estrogen metabolism in systemic lupus erythematosus: Patients and family members
69. Increased 16 alpha hydroxylation of estradiol in systemic lupus erythematosus
70. Increased oxidation of testosterone in systemic lupus erythematosus
71. Low plasma androgens in women with systemic lupus erythematosus
72. Lupus in the male: Worsened disease after treatment with 19-nortestosterone
73. Pathogenesis of the glomerulonephritis of NZB/W mice
74. Gender, biology and human disease: Report of a conference
75. The human androgen receptor: Complementary deoxyribonucleic acid cloning; sequence analysis and gene expression in prostate
76. Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study
77. Linkage between immune response potential to DNA and X chromosome
78. Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus-analyses of strain, gender, and age effects
79. Inhibitory effect of progesterone and 20-hydroxypregn-4-en-3-one on the phytohemagglutinin-induced transformation of human lymphocytes
80. Estrogen influences CD4+ T lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice
81. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation
82. Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice
83. Androgens accelerate thymocyte apoptosis
84. Use of estrogen in women with systemic lupus erythematosus-should, should not?
85. Sex based differences in gene transmission and gene expression
86. The effects of anti-estrogen therapy on lymphocyte functions in breast cancer patients
87. Oral contraceptives and systemic lupus erythematosus
88. Gender differences in autoimmune diseases: Estrogen increases calcineurin expression in systemic lupus erythematosus
89. Lupus erythematosus (erythematodes) and ovarian function: Observations on a possible relationship with a report of six cases
90. Delayed androgen treatment survival in murine lupus
91. Sex hormone modulation of autoimmunity in NZB/NZW mice
92. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice
93. Effect of androgenic steroids on rat thymus and thymocytes in suspension
94. Active E rosette formation in women taking oral contraceptives
95. Sex steroids and the immune system-I. Sex difference in autoimmune disease in NZB/NZW hybrid mice
96. Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities?
97. Androgenic status of males with SLE
98. Regulation of the immune response by sex hormones. I. In vivo effects of estradiol and testosterone on pokeweed mitogen-induced B-cell differentiation
99. Systemic lupus erythematosus in 49 Israeli males: A retrospective study
100. Treatments with tamoxifan and an antiestradiol antibody have beneficial effects on experimental SLE via cytokine modulation
101. Estrogen and human T lymphocytes: Presence of specific receptors in the T-suppressor/cytotoxic subset
102. Steroids as immunosuppressants in pregnancy
103. Peripheral blood T cells and monocytes and B cell lines derived from patients with systemic lupus erythematosus express estrogen receptor transcripts similar to those of normal cells
104. Hormones and lupus: Defective dehydroepiandrosterone activity induces impaired interleukin activity of T lymphocytes in patients with systemic lupus erythematosus
105. Antinuclear antibodies in mice. I. Influence of age and possible genetic factors on spontaneous and induced responses
106. A quantitative difference in the immune response between male and female mice
107. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis
108. Estrogenic hormones in immune responses in normal and X irradiated mice
109. The effect of induced chronic viral infections on the immunological lesions of New Zealand white mice
110. Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune diseases?
111. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus
112. Prolactin: An immune-stimulating peptide that regulates other immune-modulating hormones
113. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus
114. Prolactin: A stimulator of disease activity in systemic lupus erythematosus
115. Prevention of corneal rejection by estrogens
116. A gender gap in autoimmunity
117. Immunosuppression by sex steroid hormones. I. The effect upon PHA- and PPD-stimulated lymphocytes
118. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis